genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Astellas
Cancer
Hold and Kill: Halda Raises $126M toward Precision Cancer Treatments
Bioprocessing
Cytiva Launches Next-Gen Cell Therapy Manufacturing Platform
Artificial Intelligence
GTC 2024: Nvidia Highlights AI ‘Revolution’ in Drug Discovery, Genomics
Bioprocessing
Prime Editing for Isogenic iPSCs, PRINT, Universal In Vivo CAR T Editing, Biogen Q4 Results Disappoint; Andrea Choe
Cancer
Astellas and Kelonia Partner for $800M In Vivo CAR T Cell Therapies
Bioprocessing
Conscious Re-Coupling: M&A Comes Back Surely, If Slowly
Bioprocessing
BPI News: Opening Keynote Offers Hopeful Outlook for Cell and Gene Therapy
Bioprocessing
Astellas to Invest More than €330 Million in New Facility in Ireland
Artificial Intelligence
AI, Cell/Gene Therapy, Precision Medicine Drive Bullish Biotech Investment
Drug Discovery
Astellas to Acquire Iveric Bio for $5.9B, Expanding Eye Disease Pipeline
1
2
3
...
13
Page 1 of 13
Scroll Up
Scroll Up
